These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15162378)

  • 1. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
    Pu YS; Hour TC; Chuang SE; Cheng AL; Lai MK; Kuo ML
    Prostate; 2004 Jul; 60(2):120-9. PubMed ID: 15162378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
    Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
    Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.
    Miyamoto Y; Hosotani R; Doi R; Wada M; Ida J; Tsuji S; Kawaguchi M; Nakajima S; Kobayashi H; Masui T; Imamura M
    Anticancer Res; 2001; 21(4A):2449-56. PubMed ID: 11724306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M; De Vos J; Mechti N; Klein B
    Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY; Stein CA
    Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.
    Sonnemann J; Gekeler V; Sagrauske A; Müller C; Hofmann HP; Beck JF
    Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.
    Gagarin D; Yang Z; Butler J; Wimmer M; Du B; Cahan P; McCaffrey TA
    J Mol Cell Cardiol; 2005 Sep; 39(3):453-65. PubMed ID: 16005468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
    Alas S; Emmanouilides C; Bonavida B
    Clin Cancer Res; 2001 Mar; 7(3):709-23. PubMed ID: 11297268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides.
    Lebedeva I; Raffo A; Rando R; Ojwang J; Cossum P; Stein CA
    J Urol; 2001 Aug; 166(2):461-9. PubMed ID: 11458048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways.
    Leu CM; Wong FH; Chang C; Huang SF; Hu CP
    Oncogene; 2003 Oct; 22(49):7809-18. PubMed ID: 14586407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
    Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
    Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
    Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA
    Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2.
    Su ZZ; Lebedeva IV; Sarkar D; Emdad L; Gupta P; Kitada S; Dent P; Reed JC; Fisher PB
    Oncogene; 2006 Apr; 25(16):2339-48. PubMed ID: 16331261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL.
    Emanuele S; D'Anneo A; Bellavia G; Vassallo B; Lauricella M; De Blasio A; Vento R; Tesoriere G
    Eur J Cancer; 2004 Jun; 40(9):1441-52. PubMed ID: 15177505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.